AbbVie

ABBV | NYSE | 359 Followers

$236.38

+3.02%

$6.93

Overview Metrics Financials

Fair Price

$558.46

Overvalued by 79.0%

Για να εμφανιστεί η δίκαιη τιμή μιας μετοχής, πρέπει να είστε μέλος του Bulios Black.

Profile

AbbVie (ABBV) is a global pharmaceutical company specializing in the development and manufacturing of innovative medicines. Their portfolio includes drugs in the areas of immunology, oncology, neuroscience, and other therapeutic areas. With strong research and development capabilities, AbbVie offers a promising investment opportunity for long-term focused investors in the healthcare sector. Add ABBV stock to your watchlist on Bulios and stay informed about the latest news and innovations in the pharmaceutical industry.

Feed

500 Internal server error

500

Internal server error

Something goes wrong with our servers, please try again later.

Back to home